Your Unread Messages in Pharmacy
See All >> Messages include industry-sponsored communications and special communications from MDLinx
D Scott Cunningham MD, PhD
Site Editor, MDLinx
ASA as effective as sumatriptan in treatment of acute migraines
Jill Baker
MDLinx Career Center
NPs and PAs play crucial role amid PCP shortage
Smartest Doc Challenge
MDLinx
Clinical Pearls for Pain Managers and Prescribers
MDLinx Reminder
MDLinx
Conference Center Upgraded with New Tools
MDLinx Top Read
MDLinx
Running from that pile of unread journals?
1 A dose-ranging study of cabozantinib in men with castration-resistant prostate cancer and bone metastases Clinical Cancer Research, May 17, 2013 Clinical Article
2 Major changes in chemotherapy regimens administered to breast cancer patients during 2000-2008 in the Netherlands The Breast Journal, May 17, 2013 Clinical Article
3 Low BRAF and NRAS expression levels are associated with clinical benefit from DTIC therapy and prognosis in metastatic melanoma Clinical and Experimental Metastasis, May 17, 2013 Clinical Article
4 Prospective Phase II Single-Center Study of the Safety of a Single Very High Dose of Liposomal Amphotericin B for Antifungal Prophylaxis in Patients with Acute Myeloid Leukemia Antimicrobial Agents and Chemotherapy, May 17, 2013 Clinical Article
5 A Case of Fibrolamellar Cancer With a Palliative Response and Minor Radiographic Regression With Erlotinib and Bevacizumab Combination Therapy American Journal of Therapeutics, May 17, 2013
6 Health-related quality of life and symptoms in patients with myelofibrosis treated with ruxolitinib versus best available therapy British Journal of Haematology, May 17, 2013 Clinical Article
7 Opposing functions of psoriasin (S100A7) and koebnerisin (S100A15) in epithelial carcinogenesis Current Opinion in Pharmacology , May 17, 2013 Review Article
8 Is There a Possibility of a Cure in Patients With Colorectal Peritoneal Carcinomatosis Amenable to Complete Cytoreductive Surgery and Intraperitoneal Chemotherapy? Annals of Surgery, May 16, 2013 Clinical Article
9 Outcome of Patients with Aggressive Pseudomyxoma Peritonei Treated by Cytoreductive Surgery and Intraperitoneal Chemotherapy World Journal of Surgery, May 16, 2013 Clinical Article
10 Histone Deacetylase Inhibitors Interact with MDA-7/IL-24 to Kill Primary Human Glioblastoma Cells Molecular Pharmacology, May 16, 2013 Review Article
11 Anti-cancer effects of newly developed chemotherapeutic agent, glycoconjugated palladium (II) complex, against cisplatin-resistant gastric cancer cells Full Text BMC Cancer, May 15, 2013 Clinical Article
12 Melatonin-induced methylation of the ABCG2/BCRP promoter as a novel mechanism to overcome multidrug resistance in brain tumour stem cells British Journal of Cancer, May 15, 2013 Clinical Article
13 Apigenin sensitizes doxorubicin-resistant hepatocellular carcinoma BEL-7402/ADM cells to doxorubicin via inhibiting PI3K/Akt/Nrf2 pathway Carcinogenesis, May 15, 2013 Clinical Article
14 Treatment With Topotecan Plus Cyclophosphamide in Children With First Relapse of Neuroblastoma Pediatric Blood & Cancer, May 15, 2013 Clinical Article
15 Methotrexate binds to recombinant thiopurine S-methyltransferase and inhibits enzyme activity after high-dose infusions in childhood leukaemia European Journal of Clinical Pharmacology, May 15, 2013 Clinical Article
16 The roles of epigenetic modifications of proapoptotic BID and BIM genes in imatinib-resistant chronic myeloid leukemia cells Hematology, May 15, 2013 Clinical Article
17 ARIAD Presents New Preclinical Data Showing Ponatinib Overcomes Resistant Mutations in KIT, an Oncogenic Driver of Gastrointestinal Stromal Tumors Full Text ARIAD Pharmaceuticals, May 15, 2013
18 Concurrent sunitinib and stereotactic body radiotherapy for patients with oligometastases Targeted Oncology, May 14, 2013 Clinical Article
19 Regorafenib inhibits growth, angiogenesis and metastasis in a highly aggressive, orthotopic colon cancer model Molecular Cancer Therapeutics, May 14, 2013 Clinical Article
20 Correlation between response to chemotherapy with concomitant bevacizumab for hepatic metastasis of colorectal cancer and degree of enhancement using contrast-enhanced computed tomography Cancer Chemotherapy and Pharmacology, May 14, 2013 Clinical Article
Indexed Journals in Pharmacy: Expert Opinion in Pharmacotherapy, Formulary, U.S.Pharmacist more
Register now to view all the MDLinx contents (FREE)!
Login
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close